Research Funding Announcements | Lewy Body Dementia Association LBDA

Research Funding Announcements

Stay up-to-date on LBD-relevant funding opportunity announcements from LBDA and federal agencies like the National Institutes of Health and Department of Defense.

LBDA

None at this time. For future funding opportunities, please note LBDA's Policy on Indirect Rates.

TRAINING and MENTORING

Title: Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)
FOA NOT-OD-20-133
Issued by: Office of The Director, National Institutes of Health (OD)
Description The objective of the LRP-CR is to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers.

The NIH invites qualified health professionals who contractually agree to engage in NIH mission-relevant research for an average of at least 20 hours each week for at least two years, initially, to apply for an award in the Extramural LRP. The Extramural LRP repays up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research at a domestic, nonprofit, or government entity. Research funding from NIH is not required to participate in the Extramural LRP. LRP awards are based on an applicant's potential to build and sustain a research career.

Open Date (Earliest Submission Date): Sept. 1, 2020
Letters of Intent Due Date: n/a
Application Due Date: Nov. 20, 2020
Funds Available and Anticipated Number of Awards: The NIH intends to commit approximately $50 million annually to fund LRP-CR awards.
Award Budget The Extramural LRP repays up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research at a domestic, nonprofit, or government entity.
Award Project Period: 2 year commitment
Scientific/Research Contact: Additional detailed information about the NIH Loan Repayment Programs is provided at www.lrp.nih.gov/about_the_programs/index.aspx. Applicants are strongly encouraged to discuss their career interests with an NIH Institute or Center scientific liaison provided at this site: www.lrp.nih.gov/contact_us/contact_list.aspx.
Title: Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)
FOA NOT-OD-20-134
Issued by: Office of The Director, National Institutes of Health (OD)
Description The objective of the LRP-IDB is to recruit and retain highly qualified health professionals from disadvantaged backgrounds into clinical research careers. The emphasis on clinical research and individuals from disadvantaged backgrounds highlights the need for the involvement of a cadre of competent health professionals in clinical research.

The NIH invites qualified health professionals who contractually agree to engage in NIH mission-relevant research for an average of at least 20 hours each week for at least two years, initially, to apply for an award in the Extramural LRP. The Extramural LRP repays up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research at a domestic, nonprofit, or government entity. Research funding from NIH is not required to participate in the Extramural LRP. LRP awards are based on an applicant's potential to build and sustain a research career.

Open Date (Earliest Submission Date): Sept. 1, 2020
Letters of Intent Due Date: n/a
Application Due Date: Nov. 20, 2020
Funds Available and Anticipated Number of Awards: The NIH intends to commit approximately $1 million annually to fund LRP-IDB awards.
Award Budget The Extramural LRP repays up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research at a domestic, nonprofit, or government entity.
Award Project Period: 2 year commitment
Scientific/Research Contact: Additional detailed information about the NIH Loan Repayment Programs is provided at www.lrp.nih.gov/about_the_programs/index.aspx. Applicants are strongly encouraged to discuss their career interests with the NIMHD scientific liaison, whose contact information is provided on this web page: www.lrp.nih.gov/contact_us/contact_list.aspx.
Title: Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)
FOA NOT-OD-20-137
Issued by: Office of The Director, National Institutes of Health (OD)
Description The objective of the LRP-HDR is to recruit and retain highly qualified health professionals into research careers that focus on minority health disparities or other health disparities.

The NIH invites qualified health professionals who contractually agree to engage in NIH mission-relevant research for an average of at least 20 hours each week for at least two years, initially, to apply for an award in the Extramural LRP. The Extramural LRP repays up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research at a domestic, nonprofit, or government entity. Research funding from NIH is not required to participate in the Extramural LRP. LRP awards are based on an applicant's potential to build and sustain a research career.

Open Date (Earliest Submission Date): Sept. 1, 2020
Letters of Intent Due Date: n/a
Application Due Date: Nov. 20, 2020
Funds Available and Anticipated Number of Awards: The NIH intends to commit approximately $6 million annually to fund LRP-HDR awards.
Award Budget The Extramural LRP repays up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research at a domestic, nonprofit, or government entity.
Award Project Period: 2 year commitment
Scientific/Research Contact: Additional detailed information about the NIH Loan Repayment Programs is provided at www.lrp.nih.gov/about_the_programs/index.aspx. Applicants are strongly encouraged to discuss their career interests with an NIH Institute or Center scientific liaison provided at this site: www.lrp.nih.gov/contact_us/contact_list.aspx.
Title: Transition to Aging Research for Predoctoral Students (F99/K00)
FOA RFA-AG-21-022
Issued by: National Institute on Aging (NIA)
Description NIA invites outstanding graduate students from a wide range of broad research areas including, but not limited to, statistics, neuroscience, physics, immunology, microbiology, informatics, data sciences, psychology, (bio)behavioral science, anthropology, demography, sociology, social epidemiology, economics, public health, and engineering who are interested in receiving aging-related postdoctoral training to apply for this award.

The purpose of the Transition to Aging Research Award for Predoctoral Students is to increase, retain, and diversify the pool of trainees in aging and geriatric research.

Open Date (Earliest Submission Date): Sept. 22, 2020
Letters of Intent Due Date: n/a
Application Due Date: Oct. 22, 2020
Funds Available and Anticipated Number of Awards: NIA intends to commit $450,000 in FY 2021 to fund 7-10 awards.
Award Budget Award budgets are composed of stipends, tuition and fees, and institutional allowance
Award Project Period: Individuals may receive up to 5 years of aggregate Kirschstein-NRSA support at the predoctoral level (up to 6 years for dual degree training, e.g., MD/PhD), and up to 3 years of aggregate Kirschstein-NRSA support at the postdoctoral level, including any combination of support from institutional training grants (e.g., T32) and an individual fellowship award.
Title: Solicitation of Nominations for the 2021 National Institute of Neurological Disorders and Stroke (NINDS) Landis Award for Outstanding Mentorship
FOA NOT-NS-20-093
Issued by: Shahrooz Vahedi, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9322
Email: shahrooz.vahedi@nih.gov
Description To recognize the crucial role great mentors play in the development of future leaders in neuroscience, the National Institute of Neurological Disorders and Stroke (NINDS) created the Landis Award for Outstanding Membership. This award provides $100,000.00 (direct costs) to up to five (5) faculty members, who are considered to be outstanding mentors and trainers, to help foster the research career development of additional students and post-doctorates. 

Nominations for the NINDS Landis Mentor Award will be accepted ONLY from current and former trainees of the nominated individual.

Application Due Date: Dec. 15, 2020
Funds Available and Anticipated Number of Awards: Up to 5 awards per year
Award Budget Each award is $100,000 direct cost, in the form of an administrative supplement
Scientific/Research Contact: Stephen Korn
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-4188
Email: korns@ninds.nih.gov

LBD and ADRD FUNDING

Title: Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)
FOA: RFA-AG-21-029
Issued by: National Institute on Aging (NIA)
Description This FOA invites applications that employ integrative experimental and analytical approaches engaging basic and translational/clinical research aimed at developing a comprehensive understanding of the impact of sex differences on the trajectories of brain aging and disease, phenotypes of AD and AD-related dementias (ADRD) risk, individualized prevention, and responsiveness to pharmacologic and non-pharmacologic interventions.
Open Date (Earliest Submission Date): October 10, 2020
Letters of Intent Due Date: October 10, 2020
Application Due Date(s) November 10, 2020
Funds Available and Anticipated Number of Awards NIA intends to commit $5.5 million in FY 2021 to support 2-5 awards.
Award Budget: Annual direct costs are capped at $750,000.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Scientific/Research Contacts Jean Yuan, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: yuanx4@mail.nih.gov
Title: NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50  Clinical Trial Optional)
FOA: RFA-NS-21-001
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Description This Funding Opportunity Announcement (FOA) invites applications for the Morris K. Udall Centers of Excellence for Parkinson’s Disease Research program. The overarching goal of this program is to support specialized research Centers that work collaboratively as well as independently to define the causes of and discover improved treatments for Parkinson’s disease (PD). A more immediate goal for each Center is to rapidly advance synergistic, interdisciplinary research programs while serving as national leaders in PD research. Applicants will identify an overall research theme that directly addresses a critical challenge in PD research. The Center theme, proposed research projects, and associated cores will inform the etiology, pathogenesis, or treatment of PD; investigations on related synucleinopathies may be included if such directly address the identified PD research challenge.
Open Date (Earliest Submission Date): August 28, 2020
Letters of Intent Due Date: 30 days prior to the application due date
Application Due Date(s) September 28, 2020, September 28, 2021, September 28, 2022
Funds Available and Anticipated Number of Awards The NINDS intents to commit up to $6,750,000 total costs in fiscal year (FY) 2021. 
Award Budget: Applicants may request up to $1,000,000 direct costs per year with the follow exception: applications containing a translational project and/or clinical component (i.e. clinical research project plus a clinical core) may request up to $1,500,000 direct costs per year.
Award Project Period: The project period is limited to 5 years
Scientific/Research Contacts Beth-Anne Sieber, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5680
Email: Beth-Anne.Sieber@nih.gov
Title: NINDS Exploratory Grant Program in Parkinson's Disease Research (P20- Clinical Trial Optional
FOA: RFA-NS-21-002
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Description This Funding Opportunity Announcement (FOA) invites Exploratory Grant (P20) applications for the planning and initiation of collaborative efforts to advance Parkinson's Disease (PD) research. The goal of this program is to formalize new collaborative directions and/or novel interdisciplinary teams to address critical gaps in PD research and to establish a rigorous foundation of research discovery leading directly to an NINDS Morris K. Udall Center of Excellence (P50) application. Through this mechanism, the NINDS seeks to develop synergistic, proof-of-concept research efforts around investigator-defined gaps in PD research and support collaborative teams to develop a research plan, construct an effective administrative organization, create standardized policies/procedures, and gather rigorous preliminary data in support of novel ideas to address urgent needs and emergent issues in PD research. The Exploratory Grant theme and proposed research feasibility projects will inform the etiology, pathogenesis, or treatment of PD; investigations on related synucleinopathies may be included if such directly address the identified PD research gap.
Open Date (Earliest Submission Date): August 28, 2020
Letters of Intent Due Date: 30 days prior to the application due date
Application Due Date(s) September 28, 2020
Funds Available and Anticipated Number of Awards The NINDS intends to fund up to 4 awards in FY2021, corresponding to a total of $1.2 million in direct costs. Only one Exploratory Grant will be awarded per applicant institution.
Award Budget: Application budgets are limited to $300,000 direct costs per year (exclusive of facilities and administrative costs of subcontracts with collaborating institutions). 
Award Project Period: The maximum project period is to 2 years
Scientific/Research Contacts Beth-Anne Sieber, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5680
Email: Beth-Anne.Sieber@nih.gov
Title: Notice of Special Interest: Fundamental and Translational Research on Decision Making in Aging and/or Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD)
FOA: This Notice of Special Interest (NOSI) underscores NIA’s continued commitment to research that seeks to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in adults who are aging normally, as well as in individuals with mild cognitive impairment (MCI), Alzheimer’s disease (AD), and AD-related dementias (ADRD). Research is sought that characterizes the extent to which behavioral, psychological, and neural processes involved in decision making are differentially impacted in normal aging, MCI, and AD/ADRD. Investigations that target the influence of social factors on decision making or other factors that render older adults (with or without cognitive impairment) vulnerable to financial exploitation and other forms of mistreatment and abuse are of particular interest.
 
This NOSI also encourages preclinical and applied research on decision making that may facilitate the design of decision-supportive interventions for midlife and older adults with and without MCI and AD/ADRD. Specific opportunities include the development of decision-support interventions to leverage cognitive, emotional, social, and motivational strengths of these populations; tools to assess decisional capacities; strategies for simplifying choices and offering better defaults; and the promotion of timely adoption of optimal delegation practices (e.g., power of attorney, living wills, etc.). The use of animal models to explore the neural basis of affective, cognitive, social, and motivational parameters as they relate to age-related changes in decision making is also invited.
Scientific/Research Contacts Luke Stoeckel, Ph.D.
National Institute on Aging (NIA)
Telephone: 202-570-9388
Email: luke.stoeckel@nih.gov

Molly V. Wagster, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-594-7768
Email: wagsterm@nia.nih.gov

FOOD AND DRUG ADMINISTRATION

Title: Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional)
FOA RFA-FD-21-004
Issued by: Food and Drug Administration
Description The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for UG3/UH3 cooperative agreements to support the development of a publicly available core set(s) of COAs and their related endpoints for specific disease indications or for disease impacts that span multiple rare diseases of similar phenotypes.

The standard core set(s) can include different types of COAs (i.e. patient-reported outcome [PRO], clinician-reported outcome [ClinRO], observer-reported outcome [ObsRO], performance outcome [PerfO] instruments) and their related endpoints that assess a minimum list of impacts that matter most to patients, are likely to demonstrate change (including differences in trial arms related to disease burden, treatment burden, and if applicable, physical function) and should be reported in a clinical trial. A standard core set might be relevant across several disease populations or subgroups or be focused on attributes of a specific disease (a disease-specific or generic instrument that can adapted and applied more broadly across disease areas or across age groups).

The UG3/UH3 Phase Innovation Award Cooperative Agreement involves 2 phases. The UG3 phase will provide funding for 1 to 2 years to conduct planning activities. The UH3 phase will provide funding for 3 to 4 years to projects that successfully complete the planning activities and reach the projected milestones set in the UG3 phase.

Open Date (Earliest Submission Date): July 14, 2020
Letters of Intent Due Date: August 21, 2020
Application Due Date: October 14, 2020 by 11:59 PM Eastern Time
Funds Available and Anticipated Number of Awards: The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications. Award(s) will provide one (1) year of support and include future recommended support for four (4) additional year(s) contingent upon annual appropriations, availability of funding and satisfactory awardee performance.

FDA/CDER intends to commit up to $4,200,000 total for fiscal year 2021 to fund up to three (3) awards in support of this grant program.

Award Budget Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct and indirect):

UG3 (up to 2 years):

Combined years: up to $1,400,000 total costs/per award

It is up to the applicant to determine the number of years and budget for the UG3 phase. The application should provide justification for the number of years and budget split among the years if the UG3 phase is anticipated to take more than 1 year.

UG3 (up to 4 years):

Combined years: up to $2,700,000 total costs/award

It is up to the applicant to determine the number years and budget for the UH4 phase. The application should provide justification for the number of years for the UH3 phase and budget split among the years.

Award Project Period: The scope of the proposed project should determine the project period. The UG3 phase is limited to up to two years and the UH3 phase can request up to four years of support. The total project period for an application submitted in response to this FOA may not exceed five (5) years.
Scientific/Research Contact: Robyn Bent

Center for Drug Evaluation and Research (CDER)

Telephone: 301-796-9171

Email: robyn.bent@fda.hhs.gov

NATIONAL INSTITUTES OF HEALTH

Title: Notice of Special Interest: Dementia Care Workforce for Those Living with Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD)
FOA NOT-AG-20-026
Issued by: NIA
Description This Notice of Special Interest (NOSI) is intended to promote behavioral and social research on the dementia care workforce and the impact on outcomes for persons living with Alzheimer's disease or Alzheimer's disease-related dementia (AD/ADRD) and their families. Broad areas of interest include (1) how economic and policy factors drive the composition and quality of the dementia care workforce; (2) demographic and familial factors that influence demand for and supply of dementia care workers; (3) training and certification effects on quality and retention of dementia care workers; and (4) the development of data resources required to study these issues.
First Available Due Date: July 09, 2020
Expiration Date: November 13, 2021
Application and Submission Information This notice applies to due dates on or after July 9, 2020 and subsequent receipt dates through November 13, 2021.

Submit applications for the initiative using one of the following funding opportunity announcements (FOAs) or any reissue of these announcements through the expiration date of this notice.

  • PAR-19-070 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
  • PAR-19-071 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
Scientific/Research Contacts John Phillips, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-3136
Email: john.phillips@nih.gov

Elena Fazio, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-3136
Email: elena.fazio@nih.gov

Title: Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
Issued by: NIA, NINDS and other institutes at NIH
Description The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support and "protected time" for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate.
 
This Parent Funding Opportunity Announcement is for basic science experimental studies involving humans, referred to in NOT-OD-18-212 as “prospective basic science studies involving human participants.”  These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research.  Types of studies that should be submitted under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind.
Open Date (Earliest Submission Date): May 12, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) Standard dates apply.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Award budgets are composed of salary and other program-related expenses. The participating NIH Institutes and Centers will provide salary and fringe benefits for the award recipient (see Table of IC-Specific Information, Requirements and Staff Contacts). Further guidance on budgeting for career development salaries is provided in the SF424 (R&R) Application Guide. See also NOT-OD-17-094.
Award Project Period: The total project period may not exceed 5 years.
Scientific/Research Contacts See Table of IC-Specific Information, Requirements, and Staff Contacts
Title: Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
Issued by: NIA, NINDS and other institutes at NIH
Description The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support and "protected time" for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate.
 
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA.
Open Date (Earliest Submission Date): May 12, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) Standard dates apply.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Award budgets are composed of salary and other program-related expenses. The participating NIH Institutes and Centers will provide salary and fringe benefits for the award recipient (see Table of IC-Specific Information, Requirements and Staff Contacts). Further guidance on budgeting for career development salaries is provided in the SF424 (R&R) Application Guide. See also NOT-OD-17-094.
Award Project Period: The total project period may not exceed 5 years.
Scientific/Research Contacts See Table of IC-Specific Information, Requirements, and Staff Contacts
Title: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
Issued by: NIA, NINDS and many other NIH institutes
Description Funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, post-doctorates, and eligible investigators from underrepresented backgrounds, including those from groups that have been shown to be nationally underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.  Administrative supplements must support work within the scope of the original project.
 
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.  
Open Date (Earliest Submission Date): April 21, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) Due dates vary by awarding IC
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are limited to no more than the amount of the current parent award, and must reflect the actual needs of the proposed project. Direct costs for individual administrative supplements vary from less than $5,000 to more than $100,000 depending on the career level of the candidate. Administrative supplements end with the currently funded competitive cycle of the parent grant. Budget requests may also be limited by the awarding IC.
Award Project Period: The project and budget periods must be within the currently approved project period for the existing parent award.  
Scientific/Research Contacts See Table of IC-Specific Information, Requirements and Staff Contacts
Title: Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Exploratory Grant Program in Parkinson's Disease Research (P20- Clinical Trial Optional) (P20 Clinical Trial Optional)
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Description The goal of this program is to formalize new interdisciplinary teams to address critical gaps in PD research and establish a foundation of research discovery leading directly to an NINDS Morris K. Udall Center of Excellence for PD Research (P50) application.
Estimated Publication Date of Funding Opportunity Announcement: June 25, 2020
This FOA will utilize the P50 activity code.
Only new applications will be accepted in response to this FOA.
Application Due Date(s) First Estimated Application Due Date: September 25, 2020
Funds Available and Anticipated Number of Awards The NINDS intends to commit up to $1,800,000 in FY2021.The number of expected awards is 4, contingent upon NIH appropriations and the submission of sufficiently meritorious applications.
Award Budget: Application budgets are limited to $300,000 direct costs per year (exclusive of facilities and administrative costs of subcontracts with collaborating institutions). Budget requests should reflect the actual needs of the proposed project.
Award Project Period: The Exploratory Grant will provide up to two years of support.
Scientific/Research Contacts Beth-Anne Sieber, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
(301) 496-5680
 Beth-Anne.Sieber@nih.gov
Title: Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional)
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Description The National Institute of Neurological Disorders and Stroke (NINDS) intends to publish a Funding Opportunity Announcement (FOA) to solicit applications for the Morris K. Udall Centers of Excellence for Parkinson's Disease Research program. The overarching goal of this program is to establish a network of specialized Centers that work collaboratively as well as independently to define the causes of and discover improved treatments for Parkinson’s disease (PD). A more immediate goal for each Center is to rapidly advance synergistic, interdisciplinary research programs while serving as national leaders in PD research. Udall Centers also serve as local resources by providing research career enhancement activities for Center investigators and periodic outreach to the PD patient/advocacy community
 
Applicants to the Udall Centers program will identify and address an overall research theme that defines a critical challenge in PD research. The Center theme, proposed research projects, and associated cores will inform the etiology, pathogenesis or treatment of PD; investigations on related synucleinopathies may be included if such directly address the identified PD research challenge. Programmatic requirements of this FOA include: three or more Research Projects, including a dedicated Udall Catalyst project led by a junior investigator; an Administrative Core; at least one integrated Research Core that is essential to and accelerates the progress of two or more Research Projects; a mission statement for career enhancement of Center investigators, and a plan for periodic outreach to the local patient/advocacy community, including specific outreach events to convey Center research advances.
Estimated Publication Date of Funding Opportunity Announcement: June 25, 2020
This FOA will utilize the P50 activity code.
Only new applications will be accepted in response to this FOA.
Application Due Date(s) First Estimated Application Due Date: September 25, 2020
Funds Available and Anticipated Number of Awards The NINDS intents to commit up to $6,750,000 total costs in fiscal year (FY) 2021. NINDS expect to fund 3 awards, contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Applicants may request up to $1,000,000 direct costs per year with the following exception: applications containing a translational project and/or clinical component (i.e. clinical research project plus a clinical core) may request up to $1,500,000 direct costs per year. Application budgets must justify and reflect the actual needs of the proposed project.
Award Project Period: The project period will be five years.
Scientific/Research Contacts Beth-Anne Sieber, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
(301) 496-5680
Beth-Anne.Sieber@nih.gov
Title: Neurotoxin Exposure Treatment Parkinson’s Program: Investigator-Initiated Research Award
Issued by: Department of Defense
Description The NETP Program IIRA supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to neurotoxin exposure and treatment-related Parkinson’s research. This award mechanism supports the full spectrum of research from basic science through clinical research.
Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), August 18, 2020
Application Due Date(s) 11:59 p.m. ET, September 16, 2020
Funds Available and Anticipated Number of Awards The CDMRP expects to allot approximately $7.2M to fund approximately six IIRA applications.
Award Budget: The anticipated total costs budgeted for the entire period of performance will not exceed $1.2M.
Award Project Period: The maximum period of performance is 3 years.
Title: Neurotoxin Exposure Treatment Parkinson’s Program: Early Investigator Research Award
Issued by: Department of Defense
Description The NETP Program EIRA supports neurotoxin exposure and treatment-related Parkinson’s disease research opportunities for investigators in the early stages of their careers, under the guidance of a designated Mentor(s). The Early Investigator is considered the Principal Investigator (PI) of the application and must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of Parkinson’s disease research; however, the PI is not required to have previous Parkinson’s disease research experience.  Applications must include at least one Mentor, appropriate to the proposed research project, who has experience in Parkinson’s disease research and mentoring as demonstrated by a record of active funding, recent publications, and successful mentorship. The selected Mentor(s) should also demonstrate a clear commitment to the development of the PI toward independence as a neurotoxin exposure and treatment-related Parkinson’s disease researcher.
Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), August 18, 2020
Application Due Date(s) 11:59 p.m. ET, September 16, 2020
Funds Available and Anticipated Number of Awards The CDMRP expects to allot approximately $1.6M to fund approximately four Early Investigator Research Award applications.
Award Budget: The anticipated total costs budgeted for the entire period of performance for an FY20 NETP Program EIRA will not exceed $400,000.
Award Project Period: The maximum period of performance is 2 years.
Title: Neurotoxin Exposure Treatment Parkinson’s Program, Synergistic Idea Award
Issued by: Department of Defense
Description The NETP Program Synergistic Idea Award supports new ideas that represent synergistic approaches to neurotoxin exposure and treatment-related Parkinson’s disease research involving two to four Principal Investigators (PIs) at the Assistant Professor (or equivalent) level or above. These investigators should utilize their complementary and synergistic perspectives to address a
central problem or question in neurotoxin exposure and treatment-related Parkinson’s research. This award is designed to support both new and pre-existing partnerships and encourages participation of PIs from other research fields.
Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), August 18, 2020
Application Due Date(s) 11:59 p.m. ET, September 16, 2020
Funds Available and Anticipated Number of Awards The NETP Program Synergistic Idea Award mechanism is being offered for the first time in FY20. The CDMRP expects to allot approximately $6M to fund approximately two Synergistic Idea Award applications.
 
Award Budget: The anticipated total costs budgeted for the entire period of performance for an FY20 NETP Program SIA will not exceed $3M.
Award Project Period: The maximum period of performance is 4 years.
Title: Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Alcohol on the Onset and Progression of Alzheimer’s Disease and Its Related Dementias (R01 - Clinical Trial Optional)
Notice Number:
 
OT-AA-19-026
Issued by: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Aging (NIA)
Activity Code: R01
Description National Institute on Alcohol Abuse and Alcoholism (NIAAA) in partnership with the National Institute on Aging (NIA) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications to investigate mechanisms underlying the influence of alcohol on the onset and progression of Alzheimer’s disease and its related dementias.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and appropriate projects.

The FOA is expected to be published in Fall 2019 with an expected application due date in Spring 2020.

This FOA will utilize the R01 activity code. Details of the planned FOA are provided below.

Funds Available and Anticipated Number of Awards $3 million for 6-8 awards
Award Budget: $250,00 direct costs/year
Scientific/Research Contacts Changhai Cui, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
301-443-1678
Email: changhai.cui@nih.gov
 
Bradley C. Wise, Ph.D.
National Institute of Aging (NIA)
Telephone:301-496-9350
Email: WiseB@nia.nih.gov
Title: NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required)
Notice Number:
 
PAR-20-050
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Activity Code: K01
Description The purpose of the NINDS Postdoctoral Mentored Career Development Award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program.
Open Date (Earliest Submission Date): January 12, 2020
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply. The first standard due date for this FOA is February 12, 2020.
 
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Award budgets are composed of salary and other program-related expenses.
Award Project Period: The total project period may not exceed 48 months.
Scientific/Research Contacts Stephen Korn, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Email: korns@ninds.nih.gov
Title: Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)
Notice Number:
 
PAR-19-372
Issued by: National Institute on Minority Health and Health Disparities (NIMHD)
National Institute on Aging (NIA)
National Human Genome Research Institute (NHGRI)
Activity Code: R01
Description The purpose of this Funding Opportunity Announcement (FOA) is to support and accelerate human epigenomic investigations focused on identifying and characterizing the mechanisms by which social experiences at various stages in life, both positive and negative, affect gene function and thereby influence health trajectories or modify disease risk in racial/ethnic minority and other health disparity populations.
Open Date (Earliest Submission Date): October 06, 2019
Application Due Date(s) November 6, 2020, November 8, 2021
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 5 years
Scientific/Research Contacts Rina Das, PhD
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-496-3996
Email: dasr2@mail.nih.gov
 
Lucia Hindorff, Ph.D.
National Human Genome Research Institute
Phone: 240-271-1509
Email: hindorffl@mail.nih.gov
 
Amelia Karraker, PhD
National Institute on Aging (NIA)
Telephone: 301-496-3138
Email: Amelia.Karraker@nih.gov
Title: NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed)
Notice Number:
 
PAR-20-049
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Activity Code: K01
Description The purpose of the NINDS Postdoctoral Mentored Career Development Award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program.
Open Date (Earliest Submission Date): January 12, 2020
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply. The first standard due date for this FOA is February 12, 2020.
 
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Award budgets are composed of salary and other program-related expenses.
Award Project Period: The total project period may not exceed 48 months.
Scientific/Research Contacts Stephen Korn, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Email: korns@ninds.nih.gov
Title: Leadership Award for Alzheimer's Disease and Related Dementias Research (R35 Clinical Trial Not Allowed)
Notice Number:
 
RFA-AG-21
Issued by: National Institute on Aging (NIA)
Activity Code: R35
Description NIA is seeking applications from investigators looking to enhance their research programs to address selected NIH Alzheimer's Disease and Related Dementias Research Implementation Milestones. Investigators will be provided protected time to produce a program of investigation specific to selected goals/milestones. Investigators and their institutions will also be expected to advance more junior researchers' capacity to address selected goals/milestones.
Open Date (Earliest Submission Date): May 19, 2020
Letters of Intent Due Date: May 19, 2020
Application Due Date(s) June 19, 2020
Funds Available and Anticipated Number of Awards NIA intends to commit $5 million in FY 2021 to fund 8-10 awards.
Award Budget: Applicants may request up to $600,000 in directs costs per year. Investigators are encouraged to request what is well justified for their research program. The award amount will be determined by NIA and commensurate with current NIA support of the PD/PI.
Award Project Period: Applications may request a maximum project period of five years.
Scientific/Research Contacts Cerise Elliott, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: elliottce@nih.gov

 

Title: NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
Notice Number:
 
PAR-20-021
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Activity Code: F32 Postdoctoral Individual National Research Service Award
Description The purpose of this award is to support outstanding scientific training of highly promising postdoctoral candidates with outstanding mentors. Candidates are eligible to apply for support from this program from ~12 months prior to the start of the proposed postdoctoral position to within 12 months after starting in the proposed postdoctoral position.  This NINDS F32 seeks to foster early, goal-directed planning and to encourage applications for bold and/or innovative projects by the candidate that have the potential for significant impact. Inclusion of preliminary data is strongly discouraged; rather, this F32 seeks innovative research ideas and thoughtful plans for training and mentorship that will facilitate the development of the postdoctoral fellow into an outstanding scientist. 
Open Date (Earliest Submission Date): January 11, 2020
Application Due Date(s) February 11, 2020, June 9, 2020, and October 14, 2020, February 11, 2021, June 9, 2021, October 14, 2021, February 9, 2022, June 8, 2022, and October 11, 2022.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Award budgets are composed of stipends, tuition and fees, and institutional allowance.
Award Project Period: Individuals may receive up to 3 years of aggregate Kirschstein-NRSA support at the postdoctoral level, including any combination of support from institutional training grants (e.g., T32) and an individual fellowship award. 
Scientific/Research Contacts Stephen Korn, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-4188
Email: korns@ninds.nih.gov
Title: Aging Research Dissertation Awards to Increase Diversity (R36 Clinical Trial Not Allowed)
Notice Number:
 
PAR-19-394
Issued by: National Institute on Aging (NIA)
Activity Code: R36 Dissertation Award
Description The purpose of this Funding Opportunity Announcement (FOA) is to provide dissertation awards in all areas of research within NIA’s strategic priorities to increase the diversity of the scientific research workforce engaged in research on aging and aging-related health conditions.
Open Date (Earliest Submission Date): January 16, 2020
                                                                                                         
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: This FOA allows for budget requests to cover, per year, a salary consistent with the current fiscal year National Research Service Award (NRSA) predoctoral stipend level (https://grants.nih.gov/training/nrsa.htm#policy) and up to $20,000 for additional expenses such as fringe benefits (including health insurance for self and family members), travel to scientific meetings, and dissertation research costs in accordance with institutional policies. With the exception of costs associated with the dissertation (i.e., dissertation credits), no funds may be used to pay tuition or fees.
Award Project Period: Support is provided for up to two years.
Scientific/Research Contacts Shahrooz Vahedi, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9322
Email:shahrooz.vahedi@nih.gov
Title: Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed)
Notice Number:
 
PAS-19-392
Issued by: National Institute on Aging (NIA)
Activity Code: R03 Small Grant Program
Description This Small Research Grant (R03) will support important and innovative projects focused on basic science approaches to elucidate neurodegenerative mechanisms/pathways of Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Proposed projects should ultimately aim to improve the prevention, diagnosis, treatment, and/or care for individuals with AD/ADRD. The program seeks (i) to facilitate the next generation of researchers in the United States to pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain aging and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies toward developing new, innovative AD/ADRD research programs that leverage and build upon their existing expertise. 
Open Date (Earliest Submission Date): January 16, 2020
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization.
Funds Available and Anticipated Number of Awards NIH intends to fund an estimated 12 awards for this FOA and its companions, corresponding to a total of $1.8 million, for fiscal year 2020. Future year amounts will depend on annual appropriations..
 
Award Budget: Applications may request budgets of up to $100,000 in direct costs per year for up to two years.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 2 years.
Scientific/Research Contacts Lisa Opanashuk, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-807-5422
Email: lisa.opanashuk@nih.gov
Title: Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed)
Notice Number:
 
PAS-19-391
Issued by: National Institute on Aging (NIA)
Activity Code: R03 Small Grant Program
Description This Small Research Grant (R03) will support important and innovative projects to provide needed scientific insight to improve the prevention, diagnosis, treatment, and/or care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Specifically, this FOA will support archiving and leveraging existing data sets for analyses of projects covering a wide array of topics relating to AD/ADRD. The overall goal of this FOA is (i) to encourage the next generation of U.S. researchers to pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain aging and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies developing new, innovative AD/ADRD research programs that leverage and build upon their existing expertise.
Open Date (Earliest Submission Date): January 16, 2020
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization.
Funds Available and Anticipated Number of Awards NIH intends to fund an estimated 12 awards for this FOA and its companions, corresponding to a total of $1.8 million, for fiscal year 2020. Future year amounts will depend on annual appropriations.
Award Budget: Applications may request budgets of up to $100,000 in direct costs per year for up to two years.
Award Project Period: The scope of the project should determine the project period. The maximum project period is 2 years.
Scientific/Research Contacts Partha Bhattacharyya, Ph.D.
Division of Behavioral and Social Research
National Institute on Aging (NIA)
Telephone: 301-496-3136
Email: bhattacharyyap@mail.nih.gov
Title: Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed)
Notice Number:
 
PAS-19-393
Issued by: National Institute on Aging (NIA)
Activity Code: R03 Small Grant Program
Description This Small Research Grant Program (R03) will support important and innovative system biology projects in which more scientific insight is needed to improve the prevention, diagnosis, treatment, and care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The overall goal of this R03 program is (i) to facilitate the next generation of researchers in the United States to pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain aging and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies toward developing new, innovative AD/ADRD research programs that leverage and build upon their existing expertise.
Open Date (Earliest Submission Date): January 16, 2020
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization. 
Funds Available and Anticipated Number of Awards NIH intends to fund an estimated 12 awards for this FOA and its companions, corresponding to a total of $1.8 million, for fiscal year 2020. Future year amounts will depend on annual appropriations.
Award Budget: Applications may request budgets of up to $100,000 in direct costs per year for up to two years.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 2 years.
Scientific/Research Contacts Alison Yao, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: alison.yao@nih.gov
Title: Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
Notice Number:
 
PAR-19-374             
Issued by: National Institute on Aging (NIA)
Activity Code: U19 Research Program – Cooperative Agreements
Description This FOA allows for applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Such projects will likely involve an integrated multidisciplinary team of investigators within a single institution or a consortium of institutions.
Open Date (Earliest Submission Date): September 28, 2019
Letters of Intent Due Date: 30 days prior to the application due date
Application Due Date(s) New Dates The first submission date for this FOA is October 28, 2019. Thereafter, Standard dates apply.
 
After this off-cycle application due date, future application due dates will follow the standard due dates, with the next submission date of January 25, 2020.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: The maximum project period is 5 years.  
Scientific/Research Contacts Sanoj Suneja, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-402-7710
Email: sunejas@mail.nih.gov
Title: Notice of Special Interest: Alzheimer’s-focused administrative supplements for NIH grants that are not focused on Alzheimer’s disease
Notice Number:
 
NOT-AG-20-008
Issued by: NIA, NINDS and many other institutes
Description The participating Institutes and Centers (ICs) are inviting applications to expand existing awards that are not currently focused on Alzheimer’s disease and its related dementias (AD/ADRD)—frontotemporal dementia, Lewy body dementia, vascular cognitive impairment with dementia, and multiple etiology dementias—to allow the research to develop such a focus. Active awards with project end dates in FY 2021 or later are eligible.
First Available Due Date: March 06, 2020
Scientific/Research Contacts See NIH webpage for this notice
Title: Improving Quality of Care and Patient Outcomes During Care Transitions (R01)
Notice Number:
 
PA-20-068
Issued by: Agency for Healthcare Research and Quality (AHRQ)
Activity Code: R01
Description This Funding Opportunity Announcement (FOA) invites R01 grant applications for funding health services research that improves the quality of care and patient outcomes during transitions of care. The purpose of this FOA is to support large-scale research projects that rigorously test promising interventions aimed at improving communication and coordination during care transitions.
 
This FOA is focused on three research areas of interest

  • Care transitions between primary care, acute care, and specialty providers
  • Care transitions between different institutional care settings
  • Care transitions with a focus on patients, their families and communities
Open Date (Earliest Submission Date): December 6, 2019
Letters of Intent Due Date: n/a
Application Due Date(s) Standard dates apply. (Expiration date: December 6, 2022)
Funds Available and Anticipated Number of Awards The number of awards is contingent upon the submission of a sufficient number of meritorious applications and the availability of funds. Future year funding will depend on funding availability.
Award Budget: The total costs (direct and indirect) for a project awarded under this FOA will not exceed $400,000 in any given year and $2 million for the entire project period.
Award Project Period: The project period may not exceed 5 years.
Scientific/Research Contacts CDR Derrick L. Wyatt
Agency for Healthcare Research and Quality
Center for Evidence and Practice Improvement (CEPI)
Division of Health Information Technology
Telephone: 301-427-1506
Email: DigitalHealthcareResearch@ahrq.hhs.gov (preferred method of contact)
Title: Notice of Participation of the National Institute on Aging (NIA) in PAR-19-343 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent CT Not Allowed)
Notice Number:
 
NOT-AG-20-009
Issued by: National Institute on Aging (NIA)
Description NIA participates in NIH-wide programs to increase diversity in the research workforce. The goal of this FOA is to help outstanding postdoctoral researchers who are considered under-represented minority in science to transition into independent, tenure-track or equivalent faculty positions.  NIA welcomes applications in all fields of aging research, including basic science, diseases and disabling conditions of aging, the social and behavioral consequences of an aging society, and topics in between. A particular priority of NIA at the moment is research on Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD).
Open Date (Earliest Submission Date): Jan. 12, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization. 
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
 
 
Award Budget: Salary Support: NIA will provide K99 salary support commensurate with the applicant institution's salary structure for persons of equivalent qualifications, experience, and rank for up to $75,000 plus fringe benefits per year.
 
Research Support: NIA will provide up to $25,000 research support per year for the K99 phase of the award.
 
Other Program-Related Expenses: TRAVEL: The application may request up to $2,500 annually to defray the cost of participation in professional meetings (excluding MOSAIC associated meetings, the costs of which will be covered by the UE5 awardees).
Award Project Period: The total project period may not exceed 5 years.
Scientific/Research Contacts Shahrooz Vahedi, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9322
Email: shahrooz.vahedi@nih.gov
Title: Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
Notice Number:
 
NOT-OD-20-048
Issued by: National Institute on Aging (NIA)
National Institute of Neurological Disorders and Stroke (NINDS)
(and many NIH institutes)
Activity Code: Administrative Supplement
Description The Office of Research on Women's Health (ORWH) announces the availability of administrative supplements to support research highlighting health disparities among women in the US who are underrepresented, understudied, and underreported (U3) in biomedical research. The proposed research must address at least one objective from the strategic goals 1, 2, or 3 of the 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women."
Open Date (Earliest Submission Date): (2018)
Letters of Intent Due Date: n/a
Application Due Date(s) Due dates may vary by awarding IC.  See the awarding IC's web site for any applicable Application Due Dates.  
Award Budget: $2,000,000 is expected to be available annually for funding this program. The budget should not exceed $140,000 direct costs for the administrative supplement per year. In addition to the direct cost, applicable F&A (indirect) cost can also be requested.
The application budget is limited to one year only.  Supplements may provide support above the dollar limits of the funding opportunity announcement of the parent grant award.
Scientific/Research Contacts Rajasri Roy Ph.D., MPH
Office of Research on Women's Health (ORWH)
Telephone: 301-451-0993
Email: rajasri.roy@nih.gov
Title: Notice of Special Interest: Administrative Supplements for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)
Notice Number:
 
NOT-OD-20-049
Issued by: National Institute on Aging (NIA)
National Institute of Neurological Disorders and Stroke (NINDS)
(and many NIH institutes)
Activity Code: Administrative Supplement
Description The Office of Research on Women's Health (ORWH) announces the availability of administrative supplements to support research highlighting the impact of sex and gender influences in human health and illness. Sex and gender are important considerations in many areas of research, including basic biological, psychological, social, and behavioral studies. With continuous interaction between sex and gender, human health is determined by both biology and expression of gender. The most robust experimental designs include consideration of both sex and gender; therefore, applications proposing to investigate the influence of both sex and gender factors are highly encouraged. The proposed research must address at least one objective from the five strategic goals of the 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women".
Open Date (Earliest Submission Date): (2018)
Letters of Intent Due Date: n/a
Application Due Date(s) Due dates may vary by awarding IC.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are limited to no more than the amount of the current parent award, and must reflect the actual needs of the proposed project.
Award Project Period: The project and budget periods must be within the currently approved project period for the existing parent award.   
Scientific/Research Contacts For any scientific or research-related questions on this administrative supplement notice please contact the Program Officer listed on the NoA of the most recent parent award.
Title: Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)
Notice Number:
 
PAR-20-070
Issued by: National Institute on Aging (NIA)
Activity Code: R21/R33 Phased Innovation Award
Description This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities and up to 3 years of R33 support for expanded activities. Through this award, investigators will develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.
Open Date (Earliest Submission Date): Jan. 16, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Project Period: The duration of the entire R21/R33 award may not exceed 5 years. The R21 phase may not exceed 2 years of support. The R33 phase may not exceed 3 years of support.
Scientific/Research Contacts Winifred K. Rossi
National Institute on Aging (NIA)
Telephone: 301-496-3836
Email: rossiw@mail.nih.gov
Title: Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
Notice Number:
 
PAR-20-071
Issued by: National Institute on Aging (NIA)
Activity Code: R33 Exploratory/Developmental Grants Phase II.
Description This FOA invites applications that propose to support advanced-stage development and utilization of novel research infrastructure to advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Exploratory/Developmental Grants Phase II mechanism to provide support for expanded activities. Applicants are expected to have an existing research infrastructure developed, either through PA-12-064 or with other NIH or non-NIH support. Through this award, investigators will develop a mature and sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.
Open Date (Earliest Submission Date): Jan. 16, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) Standard dates apply. The first application due date for this FOA is February 16, 2020.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets may not exceed $499,999   in annual direct costs.
Award Project Period: The duration of the R33 award may not exceed 5 years.
Scientific/Research Contacts Winifred K. Rossi
National Institute on Aging (NIA)
Telephone: 301-496-3836
Email: rossiw@mail.nih.gov
Title: Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)
Notice Number:
 
PAR-20-076
Issued by: National Institute of Neurological Disorders and Stroke 
National Institute on Aging 
National Institute on Drug Abuse 
National Institute of Mental Health 
Activity Code: T32 Institutional National Research Service Award (NRSA)
Description The Jointly Sponsored NIH Predoctoral Training Program in the Neurosciences (JSPTPN) is an institutional program that supports broad and fundamental research training in the neurosciences. In addition to a broad education in the neurosciences, a key component will be a curriculum that provides a strong foundation in experimental design, statistical methodology and quantitative reasoning. JSPTPN programs are intended to be 2 years in duration and students may only be appointed to this training grant during the first 2 years of their graduate research training. The primary objective is to prepare students to be outstanding scientists equipped to pursue careers in neuroscience.
Open Date (Earliest Submission Date): April 26, 2020
Letters of Intent Due Date: 30 days prior to the application due date.
Application Due Date(s) May 26, 2020; May 25, 2021; May 25, 2022
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are not limited, but need to reflect the actual needs of the proposed project.
Award Project Period: Up to 5 years
Scientific/Research Contacts Applicants should refer to the (JSPTPN website) for each IC's scientific/research contact for this NRSA T32 program. Applicants should contact the Chair of the JSPTPN Steering Committee with questions about this FOA or the application itself.
Title: BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)
Notice Number:
 
RFA-NS-19-044
Issued by: NINDS, NIA and others
Activity Code: K99/R00 Career Transition Award/Research Transition Award
Description The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance workforce diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds in BRAIN Initiative research areas.
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to the companion FOA (RFA-NS-19-043)
 
Open Date (Earliest Submission Date): Jan 10, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) New
February 10, 2020; June 10, 2020; October 9, 2020; February 10, 2021; June 9, 2021; October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022
Resubmission
March 10, 2020; July 10, 2020; November 10, 2020; March 10, 2021; July 8, 2021; November 08, 2021; March 10, 2022; July 8, 2022; November 11, 2022
 
Funds Available and Anticipated Number of Awards The BRAIN Initiative intends to commit $4.0M per year in fiscal years 2020-2023 to fund an estimate of 20 awards per year.
Award Budget: Award budgets are composed of salary and other program-related expenses. See full FOA for details.
Award Project Period: The total project period may not exceed 5 years.
Scientific/Research Contacts For project relevance or scientific questions:
Edmund (Ned) Talley, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1917
Email: BRAINDIVERSITYK99R00@nih.gov
For mechanism or career development questions:
Michelle Jones-London, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7966
Email:BRAINDIVERSITYK99R00@nih.gov
 
Title: BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
Notice Number:
 
RFA-NS-19-043
Issued by: NIA NINDS and others
Activity Code: K99/R00 Career Transition Award/Research Transition Award
Description The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance workforce diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds in BRAIN Initiative research areas
 
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOA RFA-NS-19-044  .
Open Date (Earliest Submission Date): Jan. 9, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) New
February 10, 2020, June 10, 2020, October 9, 2020; February 10, 2021; June 9, 2021; October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022
Resubmission
March 10, 2020, July 10, 2020, November 10, 2020; March 10, 2021; July 8, 2021; November 08, 2021; March 10, 2022; July 8, 2022; November 11, 2022
 
Funds Available and Anticipated Number of Awards The BRAIN Initiative intends to commit $4.0M per year in fiscal years 2020-2023 to fund an estimate of 20 awards per year.
Award Budget: Award budgets are composed of salary and other program-related expenses. See full FOA for details.
Award Project Period: The total project period may not exceed 5 years.
Scientific/Research Contacts For project relevance or scientific questions:
Edmund (Ned) Talley, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1917
Email: BRAINDIVERSITYK99R00@nih.gov
For mechanism or career development questions:
Michelle Jones-London, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7966
Email: BRAINDIVERSITYK99R00@nih.gov
 
Title: Prodromal α-Synucleinopathies Consortium (PαSS) (U19 Clinical Trial Optional)
Issued by: National Institute on Aging (NIA)
National Institute of Neurological Disorders and Stroke (NINDS)
Description The PαSS U19 seeks to understand and characterize the preclinical/prodromal phase of α-synucleinopathies. The study will recruit a cohort of iRBD subjects and follow them if/until they convert to PD, LBD, or MSA, using standardized psychometric tests, clinical/neurological evaluations, and diagnostic procedures. PαSS will identify changes associated with the earliest manifestations of α-synucleinopathy disease, including biomarkers of disease progression and potential surrogate endpoints. Biomarkers of α-synucleinopathy burden may range from neurophysiology, to changes in biofluid/tissue, to neuroimaging changes. The eventual goal is to find neuroprotective interventions for α-synucleinopathies.
 
Open Date (Earliest Submission Date): May 17, 2020
Letters of Intent Due Date: May 17, 2020
Application Due Date(s) June 17, 2020  
Award Budget: Issuing IC and partner components intend to commit an estimated total of $4,275,000 to fund 1 award.
 
Application budgets are limited to $3 million in direct costs per year.
Award Project Period: The maximum project period is 5 years. 
Scientific/Research Contacts Miroslaw (Mack) Mackiewicz, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-594-7636
Email: mirsoslaw.mackiewicz@nih.gov
John Hsiao, MD
National Institute on Aging (NIA)
Telephone: 301-496-9350  
Email: jhsiao@mail.nih.gov
Debra Babcock, Ph.D., MD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9964
Email: dbabcock@mail.nih.gov
Title: Alzheimer’s Disease Sequencing Project Functional Genomics Consortium (U01 Clinical Trial Not Allowed)
Issued by: National Institute on Aging (NIA)
Description This Funding Opportunity Announcement (FOA) supports concerted efforts that take a multipronged, team-science strategy and apply high-throughput, genome-wide approaches to systematically discover and characterize functional genomic and epigenomic elements and elucidate and validate their functional roles and mechanisms of action underpinning the heterogeneity, pathogenesis, and progression of Alzheimer’s disease and related dementias (AD/ADRD).
Open Date (Earliest Submission Date): June 01, 2020
Letters of Intent Due Date: June 1, 2020
Application Due Date(s) July 1, 2020
Award Budget: NIA intends to commit $5 million in FY 2021 to support up to 3 awards. Direct costs should not exceed $1 million per year.
Award Project Period: The maximum project period is five years
Scientific/Research Contacts Alison Yao, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-827-7264
Email:alison.yao@nih.gov
Marilyn Miller, Ph.D.
National Institute on Aging
Telephone: 301-496-9350
Email: millerm@nia.nih.gov
Title: Notice of Change in Application Types Allowed for PAR-19-070 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
Issued by: National Institute on Aging (NIA)
Description This Notice informs potential applicants that the application types allowed in response to PAR-19-070 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) have been expanded to include Revision applications. This change is effective as of the July 9, 2020 application due date.
Title: Notice of Change in Application Types Allowed for PAR-19-071 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
Issued by: National Institute on Aging (NIA)
Description This Notice informs potential applicants that the application types allowed in response to PAR-19-071 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Not Allowed) have been expanded to include Revision and Resubmission applications. This change is effective as of the July 9, 2020 application due date.

*LBDA Policy on Indirect Rates
Grant proposals to LBDA should not exceed a 10% indirect rate; this is the maximum allowed for the primary applicant organization and any sub-grantees or contractors. (If a grantee has an indirect cost rate lower than 10%, they should not increase the funding to the maximum allowed.) LBDA reserves the right to allow for a higher indirect rate in rare situations as warranted. Written permission from LBDA’s contact person for the grant opportunity is required in advance of submitting a proposal with an indirect rate higher than 10%.
 

NOT-AG-20-026